Florida Senate - 2017                             CS for SB 1002
       
       
        
       By the Committee on Criminal Justice; and Senators Perry,
       Rouson, and Bradley
       
       
       
       
       591-02931-17                                          20171002c1
    1                        A bill to be entitled                      
    2         An act relating to the Florida Comprehensive Drug
    3         Abuse Prevention and Control Act; creating s. 893.015,
    4         F.S.; specifying the chapter’s purpose; providing that
    5         a reference to ch. 893, F.S., or to any section or
    6         portion thereof, includes all subsequent amendments;
    7         amending s. 893.03, F.S.; specifying that ioflupane
    8         (123I) is not included in Schedule II of the standards
    9         and schedules of controlled substances; providing an
   10         effective date.
   11          
   12  Be It Enacted by the Legislature of the State of Florida:
   13  
   14         Section 1. Section 893.015, Florida Statutes, is created to
   15  read:
   16         893.015Statutory references.The purpose of this chapter
   17  is to comprehensively address drug abuse prevention and control
   18  in this state. To this end, unless expressly provided otherwise,
   19  a reference in any section of the Florida Statutes to chapter
   20  893 or to any section or portion of a section of chapter 893
   21  includes all subsequent amendments to chapter 893 or to the
   22  referenced section or portion of a section.
   23         Section 2. Paragraph (a) of subsection (2) of section
   24  893.03, Florida Statutes, is amended to read:
   25         893.03 Standards and schedules.—The substances enumerated
   26  in this section are controlled by this chapter. The controlled
   27  substances listed or to be listed in Schedules I, II, III, IV,
   28  and V are included by whatever official, common, usual,
   29  chemical, trade name, or class designated. The provisions of
   30  this section shall not be construed to include within any of the
   31  schedules contained in this section any excluded drugs listed
   32  within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
   33  Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
   34  Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
   35  Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
   36  Anabolic Steroid Products.”
   37         (2) SCHEDULE II.—A substance in Schedule II has a high
   38  potential for abuse and has a currently accepted but severely
   39  restricted medical use in treatment in the United States, and
   40  abuse of the substance may lead to severe psychological or
   41  physical dependence. The following substances are controlled in
   42  Schedule II:
   43         (a) Unless specifically excepted or unless listed in
   44  another schedule, any of the following substances, whether
   45  produced directly or indirectly by extraction from substances of
   46  vegetable origin or independently by means of chemical
   47  synthesis:
   48         1. Opium and any salt, compound, derivative, or preparation
   49  of opium, except nalmefene or isoquinoline alkaloids of opium,
   50  including, but not limited to the following:
   51         a. Raw opium.
   52         b. Opium extracts.
   53         c. Opium fluid extracts.
   54         d. Powdered opium.
   55         e. Granulated opium.
   56         f. Tincture of opium.
   57         g. Codeine.
   58         h. Ethylmorphine.
   59         i. Etorphine hydrochloride.
   60         j. Hydrocodone.
   61         k. Hydromorphone.
   62         l. Levo-alphacetylmethadol (also known as levo-alpha
   63  acetylmethadol, levomethadyl acetate, or LAAM).
   64         m. Metopon (methyldihydromorphinone).
   65         n. Morphine.
   66         o. Oxycodone.
   67         p. Oxymorphone.
   68         q. Thebaine.
   69         2. Any salt, compound, derivative, or preparation of a
   70  substance which is chemically equivalent to or identical with
   71  any of the substances referred to in subparagraph 1., except
   72  that these substances may shall not include the isoquinoline
   73  alkaloids of opium.
   74         3. Any part of the plant of the species Papaver somniferum,
   75  L.
   76         4. Cocaine or ecgonine, including any of their
   77  stereoisomers, and any salt, compound, derivative, or
   78  preparation of cocaine or ecgonine, except that these substances
   79  may not include ioflupane (123I).
   80         Section 3. This act shall take effect July 1, 2017.